首页 | 本学科首页   官方微博 | 高级检索  
文章检索
  按 检索   检索词:      
出版年份:   被引次数:   他引次数: 提示:输入*表示无穷大
  收费全文   41764篇
  免费   3329篇
  国内免费   2437篇
  47530篇
  2024年   60篇
  2023年   484篇
  2022年   1132篇
  2021年   1965篇
  2020年   1223篇
  2019年   1506篇
  2018年   1410篇
  2017年   1084篇
  2016年   1623篇
  2015年   2427篇
  2014年   2848篇
  2013年   3089篇
  2012年   3586篇
  2011年   3398篇
  2010年   1943篇
  2009年   1794篇
  2008年   2086篇
  2007年   1867篇
  2006年   1604篇
  2005年   1420篇
  2004年   1199篇
  2003年   1053篇
  2002年   905篇
  2001年   851篇
  2000年   740篇
  1999年   716篇
  1998年   435篇
  1997年   464篇
  1996年   441篇
  1995年   390篇
  1994年   378篇
  1993年   308篇
  1992年   441篇
  1991年   383篇
  1990年   331篇
  1989年   246篇
  1988年   236篇
  1987年   198篇
  1986年   141篇
  1985年   185篇
  1984年   121篇
  1983年   104篇
  1982年   80篇
  1981年   60篇
  1980年   55篇
  1979年   72篇
  1978年   66篇
  1977年   46篇
  1976年   48篇
  1973年   48篇
排序方式: 共有10000条查询结果,搜索用时 0 毫秒
941.
942.
943.
944.
945.
Caveolin‐1 (Cav1) is down‐regulated during MK4 (MDCK cells harbouring inducible Ha‐RasV12 gene) transformation by Ha‐RasV12. Cav1 overexpression abrogates the Ha‐RasV12‐driven transformation of MK4 cells; however, the targeted down‐regulation of Cav1 is not sufficient to mimic this transformation. Cav1‐silenced cells, including MK4/shCav1 cells and MDCK/shCav1 cells, showed an increased cell area and discontinuous junction‐related proteins staining. Cellular and mechanical transformations were completed when MDCK/shCav1 cells were treated with medium conditioned by MK4 cells treated with IPTG (MK4+I‐CM) but not with medium conditioned by MK4 cells. Nanoparticle tracking analysis showed that Ha‐RasV12‐inducing MK4 cells increased exosome‐like microvesicles release compared with their normal counterparts. The cellular and mechanical transformation activities of MK4+I‐CM were abolished after heat treatment and exosome depletion and were copied by exosomes derived from MK4+I‐CM (MK4+I‐EXs). Wnt5a, a downstream product of Ha‐RasV12, was markedly secreted by MK4+I‐CM and MK4+I‐EXs. Suppression of Wnt5a expression and secretion using the porcupine inhibitor C59 or Wnt5a siRNA inhibited the Ha‐RasV12‐ and MK4+I‐CM‐induced transformation of MK4 cells and MDCK/shCav1 cells, respectively. Cav1 down‐regulation, either by Ha‐RasV12 or targeted shRNA, increased frizzled‐2 (Fzd2) protein levels without affecting its mRNA levels, suggesting a novel role of Cav1 in negatively regulating Fzd2 expression. Additionally, silencing Cav1 facilitated the internalization of MK4+I‐EXs in MDCK cells. These data suggest that Cav1‐dependent repression of Fzd2 and exosome uptake is potentially relevant to its antitransformation activity, which hinders the activation of Ha‐RasV12‐Wnt5a‐Stat3 pathway. Altogether, these results suggest that both decreasing Cav1 and increasing exosomal Wnt5a must be implemented during Ha‐RasV12‐driven cell transformation.  相似文献   
946.
Alzheimer’s disease (AD) is the most common cause of dementia among elderly population. Deranged β-amyloid (Aβ) trafficking across the blood–brain barrier is known to be a critical element in the pathogenesis of AD. In the vascular endothelial cells of hippocampus, Aβ transport is mainly mediated by low-density lipoprotein-associated protein 1 (LRP1) and the receptor for advanced glycation end (RAGE) products; therefore, LRP1 and RAGE endothelial cells are potential therapeutic targets for AD. In this study, we explored the effects of Formononetin (FMN) on learning and memory improvement in APP/PS1 mice and the related mechanisms. We found that FMN significantly improved learning and memory ability by suppressing Aβ production from APP processing, RAGE-dependent inflammatory signaling and promoted LRP1-dependent cerebral Aβ clearance pathway. Moreover, FMN treatment alleviated ultrastructural changes in hippocampal vascular endothelial cells. In conclusion, we believe that FMN may be an efficacious and promising treatment for AD.  相似文献   
947.
Melatonin has been reported to have tumor-suppressive effects via comprehensive molecular mechanisms, and long non-coding RNAs (lncRNAs) may participate in this process. However, the mechanism by which melatonin affects the function of lncRNAs in triple-negative breast cancer (TNBC), the most aggressive subtype of breast cancer, is still unknown. Therefore, we aimed to investigate the differentially expressed mRNAs and lncRNAs in melatonin-treated TNBC cells and the interaction mechanisms. Microarray analyses were performed to identify differentially expressed mRNAs and lncRNAs in TNBC cell lines after melatonin treatment. To explore the functions and underlying mechanisms of the mRNAs and lncRNAs candidates, a series of in vitro experiments were conducted, including CCK-8, Transwell, colony formation, luciferase reporter gene, and RNA immunoprecipitation (RIP) assays, and mouse xenograft models were established. We found that after melatonin treatment, FUNDC1 and lnc049808 downregulated in TNBC cell lines. Knockdown of FUNDC1 and lnc049808 inhibited TNBC cell proliferation, invasion, and metastasis. Moreover, lnc049808 and FUNDC1 acted as competing endogenous RNAs (ceRNAs) for binding to miR-101. These findings indicated that melatonin inhibited TNBC progression through the lnc049808-FUNDC1 pathway and melatonin could be used as a potential therapeutic agent for TNBC.Subject terms: Breast cancer, Non-coding RNAs  相似文献   
948.
Ma  Jun  Chen  Yiyun  Wu  Wei  Chen  Zhongzhou 《中国病毒学》2021,36(5):1104-1112
Virologica Sinica - SARS-CoV-2 has become a global pandemic threatening human health and safety. It is urgent to find effective therapeutic agents and targets with the continuous emergence of novel...  相似文献   
949.
将EB病毒蛋白质BARF-1和EC-LF4与NBRF蛋白质库的序列进行局部同源性检索以及与已知的Ig V或C功能区相关分子进行对准比较,检查了同源性积分的统计学意义,并进行了二级结构预测和疏水性分析,确定了BARF-1的第13-124位和第126-221位残基片段分别与V和C样功能区类似,EC-LF4的第20-135位残基片段与V样功能区相似,BARF-1是非膜蛋白,EC-LF4是膜整合蛋白,其胞外部分近膜侧有一个类似于Ig绞链区的序列。因此,BARF-1与Ig轻链结构相似,EC-LF4与CD8抗原的第一条链相似。根据Ig超族分子的一般功能(即介导细胞粘附和细胞识别),推测EC-LF4可能作为一种粘附分子与淋巴细胞表面的Ig相关分子结合而促进EB病毒对淋巴细胞的感染。BARF-1因已知与病毒复制有关,与Ig超族的一般功能无关。EC-LF4和BARF-1的Ig样功能区可能来源于EB病毒对宿主细胞Ig基因的整合。  相似文献   
950.
设为首页 | 免责声明 | 关于勤云 | 加入收藏

Copyright©北京勤云科技发展有限公司  京ICP备09084417号